Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
0.840
-0.001 (-0.11%)
Dec 20, 2024, 4:00 PM EST - Market closed
Gossamer Bio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Cash & Equivalents | 28.46 | 32.11 | 111.97 | 183.4 | 486.06 | 135.03 | Upgrade
|
| Short-Term Investments | 298.57 | 264.32 | 143.71 | 141.82 | 26.57 | 266.74 | Upgrade
|
| Cash & Short-Term Investments | 327.03 | 296.43 | 255.68 | 325.22 | 512.63 | 401.77 | Upgrade
|
| Cash Growth | -0.56% | 15.94% | -21.38% | -36.56% | 27.59% | 75.71% | Upgrade
|
| Other Receivables | - | - | - | 0.2 | 0.2 | 1.5 | Upgrade
|
| Receivables | 6.59 | - | - | 0.2 | 0.2 | 1.5 | Upgrade
|
| Prepaid Expenses | 10.65 | 10.09 | 6.2 | 6.3 | 8.93 | 5.99 | Upgrade
|
| Restricted Cash | - | - | - | 0.06 | 0.57 | 0.06 | Upgrade
|
| Total Current Assets | 344.27 | 306.52 | 261.88 | 331.78 | 522.32 | 409.32 | Upgrade
|
| Property, Plant & Equipment | 6.33 | 4.78 | 9.89 | 10.8 | 16.08 | 15.73 | Upgrade
|
| Other Long-Term Assets | 0.28 | 0.62 | 0.68 | 1.08 | 1.03 | 1.56 | Upgrade
|
| Total Assets | 350.88 | 311.92 | 272.45 | 343.66 | 539.43 | 426.6 | Upgrade
|
| Accounts Payable | 3.06 | 5.53 | 1.46 | 3.24 | 7.51 | 0.96 | Upgrade
|
| Accrued Expenses | 25.95 | 31.16 | 33.18 | 31.34 | 27.51 | 33.61 | Upgrade
|
| Current Portion of Long-Term Debt | - | 11.61 | 11.61 | - | - | - | Upgrade
|
| Current Portion of Leases | 1.75 | 3.3 | 2.98 | 2.9 | 3.63 | 2.35 | Upgrade
|
| Other Current Liabilities | - | - | - | 2.38 | - | - | Upgrade
|
| Total Current Liabilities | 51.09 | 51.6 | 49.23 | 39.86 | 38.65 | 36.92 | Upgrade
|
| Long-Term Debt | 197.29 | 197.41 | 207.7 | 179.12 | 172.39 | 28.46 | Upgrade
|
| Long-Term Leases | 4.59 | 0.14 | 3.45 | 3.22 | 7.71 | 8.74 | Upgrade
|
| Total Liabilities | 296.74 | 249.15 | 260.37 | 222.19 | 218.75 | 74.12 | Upgrade
|
| Common Stock | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 1,292 | 1,275 | 1,045 | 932.94 | 897.61 | 686.39 | Upgrade
|
| Retained Earnings | -1,236 | -1,212 | -1,032 | -811.53 | -577.53 | -334.17 | Upgrade
|
| Comprehensive Income & Other | -2.23 | -0.35 | -0.57 | 0.05 | 0.6 | 0.26 | Upgrade
|
| Total Common Equity | 54.14 | 62.77 | 12.08 | 121.46 | 320.68 | 352.49 | Upgrade
|
| Shareholders' Equity | 54.14 | 62.77 | 12.08 | 121.46 | 320.68 | 352.49 | Upgrade
|
| Total Liabilities & Equity | 350.88 | 311.92 | 272.45 | 343.66 | 539.43 | 426.6 | Upgrade
|
| Total Debt | 203.63 | 212.46 | 225.74 | 185.24 | 183.73 | 39.55 | Upgrade
|
| Net Cash (Debt) | 123.41 | 83.96 | 29.94 | 139.98 | 328.9 | 362.22 | Upgrade
|
| Net Cash Growth | 9.15% | 180.44% | -78.61% | -57.44% | -9.20% | 58.41% | Upgrade
|
| Net Cash Per Share | 0.55 | 0.55 | 0.35 | 1.87 | 4.80 | 6.62 | Upgrade
|
| Filing Date Shares Outstanding | 226.6 | 225.58 | 94.93 | 75.76 | 73.88 | 61.69 | Upgrade
|
| Total Common Shares Outstanding | 226.6 | 225.41 | 94.42 | 75.75 | 73.87 | 61.64 | Upgrade
|
| Working Capital | 293.18 | 254.92 | 212.65 | 291.92 | 483.67 | 372.39 | Upgrade
|
| Book Value Per Share | 0.24 | 0.28 | 0.13 | 1.60 | 4.34 | 5.72 | Upgrade
|
| Tangible Book Value | 54.14 | 62.77 | 12.08 | 121.46 | 320.68 | 352.49 | Upgrade
|
| Tangible Book Value Per Share | 0.24 | 0.28 | 0.13 | 1.60 | 4.34 | 5.72 | Upgrade
|
| Machinery | 1.41 | 4.47 | 7.32 | 6.91 | 5.49 | 4.28 | Upgrade
|
| Construction In Progress | - | - | 0.08 | - | 0.02 | 0.05 | Upgrade
|
| Leasehold Improvements | 2.56 | 2.56 | 2.56 | 2.56 | 2.54 | 2.23 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.